Park Square has placed Frederick Beddingfield III, M.D., Ph.D., as Chief Executive Officer at Rubedo Life Sciences.
{
Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies targeting senescent cells which drive age-related diseases, today announced the appointment of Frederick C. Beddingfield III, M.D., Ph.D., as Chief Executive Officer and board director.
unknownx500
More posts by Park Square Executive Search
Recent posts from Park Square Executive Search
